about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionGenome-wide association study in alopecia areata implicates both innate and adaptive immunityViral Evasion of Natural Killer Cell ActivationHuman cytomegalovirus infection elicits new decidual natural killer cell effector functions.Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D LigandsGlycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionCEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signalingTwo novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationIncreasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionN-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICBNKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational studyRedirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.Regulation of ligands for the NKG2D activating receptor.Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.Genetics, genomics, and evolutionary biology of NKG2D ligands.CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation.Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.Natural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusThe NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathiesChimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.Effect of NKG2D ligand expression on host immune responsesγδ T cell receptor ligands and modes of antigen recognitionManipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response.Immunogenetics of the NKG2D ligand gene family.The use of microRNA by human viruses: lessons from NK cells and HCMV infection.Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?Comparative genomics of the NKG2D ligand gene family.Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity.DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cellsThe genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation.Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoformA short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.Umbilical cord blood plasma contains soluble NKG2D ligands that mediate loss of natural killer cell function and cytotoxicity.Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasmsHuman cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
P2860
Q21131219-7EBBBBCC-E6C2-43B8-9013-887A06C45A8BQ24632461-0CBE290D-D092-489C-81DF-DAB709F06E24Q26748421-AA09A125-71C0-40FD-BFDD-1255ADF7088CQ27335494-B05C9CB2-41EA-466C-83F3-3E4BF8D37299Q27659082-E3B41C0F-CD28-4D4D-850D-72E902DAAC34Q28076151-7A610DB0-8E25-4D81-A06B-189349C6FA87Q28115742-D0BF0361-F24F-416C-8954-0ED184CF6E90Q33553680-5A1DD356-9117-4D86-9406-97CC7F2DAD80Q33761979-992AE111-455B-4693-B9FF-08371746475AQ33931165-B9E405B4-DF2E-4CFD-828E-D6B19257CE48Q34079158-65A00465-5F76-4E9D-9DA2-5A4C8DDE179AQ34132372-4E17E692-DDC7-4AE7-A8DC-D30690DECA64Q34166288-53B24287-72C8-433F-82AF-915192574B8BQ34321457-2D448281-77E2-4E04-9F20-F6782D47A96FQ34368956-81379699-B27A-428F-80A1-B541C61FE85CQ34489980-0C4E80D9-923A-4F3B-85A0-A17D1F5B382EQ35055326-C32967A0-B217-4A18-9A25-120BE803B1EEQ35861220-B72984E3-FF51-40C3-A2BE-B2625828D60BQ36118554-8F656F17-044B-4E7E-BC84-67874F3402AFQ36685376-30D166D1-03B3-4023-BD16-EEDC196632D5Q36720681-2F2120E3-309F-46E9-AD30-CE2EFC795FBEQ37747044-070851A5-B39F-449B-BBA0-8C0FDA8C6207Q37764003-F9DE916B-639F-477E-9D1D-D210727BC79FQ37836561-C9A7F4A9-3999-46C4-802B-A1EBF30C9831Q38008345-56C62B20-4B2E-49C0-8880-C7040AB3DD40Q38030461-0777965A-F530-4FA6-A8CE-4C5FC03238D4Q38252422-80B22736-CA8B-41E4-9090-8285D4FF1FA9Q38270735-35D1D2A9-0273-42A4-8A07-24D5E0DEB796Q38568863-6D1522EE-1C31-44F1-BECC-44B5FA81F20CQ38940720-35ACB916-B750-4B08-B849-6D710E20A1FFQ39159252-24C2695E-F146-4CEA-95D0-F240748C8A08Q39227235-783D19DB-1824-4C18-86AB-CC76CF05425CQ39544554-19D01F0D-D339-4DFE-B1E1-DA31F2526DE0Q39725225-407044C9-2E1C-4B08-9F8A-31DC963CE72CQ40144217-05454998-6ED1-4587-B43D-68A35B00E842Q41216339-4BE6DB7A-25FC-4926-9F86-2B30D97D9314Q41699529-8FA6E832-CB0B-468A-8A20-78F30BE5D8E2Q41858506-3AA1D0A3-A0D2-455D-B2F5-1A239481C9CCQ41861099-3D42B663-2977-4D64-AA1E-12610BE035D7Q42573534-9E032C3C-1BA7-4E29-BFF1-39C53021C3F9
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
ULBP6/RAET1L is an additional human NKG2D ligand.
@ast
ULBP6/RAET1L is an additional human NKG2D ligand.
@en
ULBP6/RAET1L is an additional human NKG2D ligand.
@nl
type
label
ULBP6/RAET1L is an additional human NKG2D ligand.
@ast
ULBP6/RAET1L is an additional human NKG2D ligand.
@en
ULBP6/RAET1L is an additional human NKG2D ligand.
@nl
prefLabel
ULBP6/RAET1L is an additional human NKG2D ligand.
@ast
ULBP6/RAET1L is an additional human NKG2D ligand.
@en
ULBP6/RAET1L is an additional human NKG2D ligand.
@nl
P2093
P2860
P356
P1476
ULBP6/RAET1L is an additional human NKG2D ligand.
@en
P2093
Insiya Jafferji
James A Traherne
James R Hair
John Trowsdale
Robert A Eagle
P2860
P304
P356
10.1002/EJI.200939502
P407
P577
2009-11-01T00:00:00Z